NUTX — Nutex Health Inc. stock price and chart

NUTX

$198.99+4.05%

as of close, Oct 20, 2026

☾ AH $198.99 +4.05%

Nutex Health Inc.Stock · HealthcareRussell 2000 · 0.03% of IWMUS Stock Market · 0.001% of VTIRussell 3000 · 0.0010% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Apr 7, 2022

VolumeSS

20222023202420252026

200.0400.0600.0800.01000.01200.01400.01600.01800.001.0M2.0M$198.99

2026-10-20

Price$198.99

MA20$192.36

MA50$156.76

Vol301.6K

What would $1,000 invested in NUTX be worth today? →

NUTX returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $198.99
YTD price return: +20.88%
YTD total return: +20.88%
Next earnings: Nov 18, 2026
Market cap: 1.4B2022-06 314.3B2026-10 1.4B-99.6% over the window
Enterprise value: 1.6B
Shares outstanding: 6.8M2016-06 39.7M2026-06 6.8M-82.7% over the window
52W low: $83.99
52W high: $226.16
From 52W high: -12.01%
From 52W low: +136.92%
52W range: 81%

Volume

Rel volume: 0.67×
30D volume: 153K
30D $ vol: 31.9M

Fundamentals

Sales (ttm): 846.7M2016-06 820.3K2026-06 846.7M+103125.1% over the window
Sales/share: $123.652016-06 $0.022026-06 $123.65+598089.0% over the window
EPS (ttm): $25.522016-12 -$0.192026-06 $25.52-13728.9% over the window
FCF (ttm): 274.2M2016-06 -57K2026-06 274.2M-481393.8% over the window
FCF/share: $40.042016-06 -$0.002026-06 $40.04-2789196.5% over the window
Book value/share: $57.582016-06 $0.032026-06 $57.58+186223.5% over the window
Net margin: 21.25%2016-06 -6.7%2026-06 21.2%-419.4% over the window
ROE: 45.63%2016-06 -4.4%2026-06 45.6%-1125.4% over the window
ROA: 18.65%2016-06 -0.7%2026-06 18.7%-2656.3% over the window
Debt / equity: 0.08×2019-09 0.012026-06 0.08+525.1% over the window
Current ratio: 5.002016-06 0.252026-06 5.00+1910.2% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.89%2025-06-30 → 2026-06-30792.2M → 846.7M (+6.9% total)+60.23%2023-09-30 → 2026-06-30231.7M → 846.7M (+265.4% total)+20.16%2021-06-30 → 2026-06-30338M → 846.7M (+150.5% total)+100.18%2016-06-30 → 2026-06-30820.3K → 846.7M (+103125.1% total)
Net income: +219.10%2025-06-30 → 2026-06-3056.4M → 179.9M (+218.8% total)n/a+6.38%2021-06-30 → 2026-06-30132.1M → 179.9M (+36.2% total)n/a
FCF: +229.65%2025-06-30 → 2026-06-3083.2M → 274.2M (+229.4% total)n/a+20.51%2021-06-30 → 2026-06-30107.9M → 274.2M (+154.1% total)n/a
Shares: +3.84%2025-06-30 → 2026-06-306.6M → 6.8M (+3.8% total)-78.20%2023-06-30 → 2026-06-30661.9M → 6.8M (-99.0% total)-30.44%2021-06-30 → 2026-06-3042M → 6.8M (-83.7% total)-16.12%2016-06-30 → 2026-06-3039.7M → 6.8M (-82.7% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +161.14%2025-06-30 → 2026-06-30$9.78 → $25.52 (+161.0% total)n/a+158.15%2021-06-30 → 2026-06-30$0.22 → $25.52 (+11356.6% total)n/a
Sales/share: +2.94%2025-06-30 → 2026-06-30$120.12 → $123.65 (+2.9% total)+37.22%2023-09-30 → 2026-06-30$51.82 → $123.65 (+138.6% total)+72.75%2021-06-30 → 2026-06-30$8.04 → $123.65 (+1438.1% total)+138.64%2016-06-30 → 2026-06-30$0.02 → $123.65 (+598089.0% total)
FCF/share: +217.47%2025-06-30 → 2026-06-30$12.62 → $40.04 (+217.2% total)n/a+73.25%2021-06-30 → 2026-06-30$2.57 → $40.04 (+1460.3% total)n/a
Book value/share: +61.48%2025-06-30 → 2026-06-30$35.67 → $57.58 (+61.4% total)+643.46%2023-06-30 → 2026-06-30$0.14 → $57.58 (+41050.6% total)+72.08%2021-06-30 → 2026-06-30$3.82 → $57.58 (+1408.4% total)+112.36%2016-06-30 → 2026-06-30$0.03 → $57.58 (+186223.5% total)
Price: +79.34%2025-10-20 → 2026-10-20$111.00 → $198.99 (+79.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+87.93%2023-10-20 → 2026-10-20$29.97 → $198.99 (+564.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-48.34%2022-04-05 → 2026-10-20$3,996.00 → $198.99 (-95.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +79.34%2025-10-20 → 2026-10-20$111.00 → $198.99 (+79.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+87.93%2023-10-20 → 2026-10-20$29.97 → $198.99 (+564.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-48.34%2022-04-05 → 2026-10-20$3,996.00 → $198.99 (-95.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 7.8×2022-06 5799.992026-10 7.57-99.9% over the window
Fwd P/E: 9.8×
P/S (ttm)Market cap ÷ TTM revenue.: 1.6×2022-06 986.752026-10 1.61-99.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.5×2022-06 597.932026-10 3.46-99.4% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 5.0×2022-06 3407.422026-10 4.97-99.9% over the window
EV/EBITDA (fy): 4.2×
EV/Sales (ttm): 1.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 20.12%2022-03 0.1%2026-06 23.4%+44742.3% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-03-31) = 1 − 6.8M ÷ 6.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -11.35%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-11.35%) + dividends paid over that year ($0) ÷ market_cap_at(2025-03-31) ($281.6M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -11.35%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($55.7M) ÷ today's market cap ($1.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 4.09%2022-03 0.0%2026-06 4.8%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $55.7M + TTM dividends $0) ÷ today's market cap ($1.4B). Same caveat as the cash buyback yield.: 4.09%2022-03 0.0%2026-06 4.8%

Vs own 10Y history

P/S: 65th
P/B: 57th
P/FCF: 25th

Bar = where today’s multiple sits in NUTX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+4.05%

-2.63%

-4.69%

+23.24%

YTD

+20.88%

+79.27%

—

Financial statements

Open full NUTX financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

NUTX — Nutex Health Inc. price, chart and key statistics